Stinging Nettle Herb

Urtica dioica herba/folium

Evidence Rating

C Moderate

Confidence Level

Moderate

Traditions

Western

Last Updated

2/9/2026

Summary

Stinging nettle leaf/herb is approved by Commission E and ESCOP for adjuvant treatment of rheumatic and arthritic conditions and as a diuretic for urinary tract inflammation. It acts through NF-kB inhibition, COX-1/2 inhibition, and H1-receptor antagonism. The Mittman (1990) study provided initial evidence for allergic rhinitis, and in vitro work shows multi-target anti-allergic mechanisms. The herb is distinct from nettle root (used for BPH) and should not be confused with it. Safety profile is excellent with minimal side effects.

⚠️

Drug Interactions

This herb has significant drug interactions. Do not use if you are taking medications without consulting a healthcare provider first. See detailed interaction information below.

Regulatory Status

Regulatory BodyStatus
Commission E (Germany)âś“ Approved
ESCOP (European)âś“ Approved
EMA/HMPC (EU)âś“ Approved

Metadata

FieldDetail
Common Names (EN)Stinging nettle (leaf/herb), common nettle, nettle leaf
Common Names (DE)Brennnessel (Blatt/Kraut), Grosse Brennnessel
Botanical NameUrtica dioica L., Urtica urens L.
Plant FamilyUrticaceae
Part UsedLeaves and aerial herb (Urticae folium/herba) — NOT root
Evidence Quality RatingMedium — Commission E and ESCOP monographed; moderate clinical trial evidence for arthritis; limited trial evidence for allergy

Approved Indications

Commission E (Germany)

  • Internally: Supportive treatment of rheumatic complaints
  • Internally: Irrigation therapy for inflammatory diseases of the lower urinary tract
  • Internally: Irrigation for prevention and treatment of renal gravel (kidney stones)

ESCOP

  • Adjuvant in the symptomatic treatment of arthritis, arthroses, and/or rheumatic conditions
  • Enhancement of renal elimination of water in inflammatory complaints of the lower urinary tract

EMA/HMPC

  • Traditional use: For relief of minor articular pain
  • Traditional use: As a diuretic to increase the amount of urine to achieve flushing of the urinary tract as an adjunct in minor urinary complaints
  • Classification: Traditional use (not well-established use)

Agreement/Disagreement Analysis

All three bodies agree on rheumatic/articular use and diuretic/urinary tract irrigation. The ESCOP monograph is the most specific about arthritis and arthrosis. None of the official monographs include allergic rhinitis, which remains an off-label/research indication despite promising mechanistic and preliminary clinical data.


Conditions Treated

Approved/Monographed

  • Rheumatic complaints (arthritis, arthrosis, rheumatic conditions)
  • Inflammatory diseases of the lower urinary tract (irrigation therapy)
  • Renal gravel prevention (Commission E)

Researched but Not Formally Approved

  • Allergic rhinitis (hay fever) — preliminary clinical and strong in vitro evidence
  • Gout (traditional use)
  • General anti-inflammatory adjunct

Mechanism of Action

Key Active Compounds

  • Caffeic acid esters (caffeoylmalic acid, chlorogenic acid) — anti-inflammatory
  • Flavonoids (quercetin, rutin, kaempferol) — antioxidant, anti-allergic
  • 13-Hydroxyoctadecatrienoic acid (13-HOTrE) — anti-inflammatory (key compound in Hox alpha extract)
  • Organic acids (caffeic acid, ferulic acid)
  • Minerals (silicic acid, potassium, calcium, iron)
  • Sterols (beta-sitosterol)

Anti-Rheumatic/Anti-Inflammatory Pathways

  • NF-kB inhibition: Standardized nettle extracts suppress cytokine production through inhibition of NF-kB activation, achieved by preventing degradation of its inhibitory subunit IkB-alpha
  • Matrix metalloproteinase (MMP) suppression: Hox alpha extract and 13-HOTrE significantly suppress IL-1beta-induced expression of MMP-1, MMP-3, and MMP-9 in human chondrocytes in vitro — relevant to cartilage degradation in OA
  • COX-1 and COX-2 inhibition: Reduces prostaglandin synthesis

Anti-Allergic Pathways (Rhinitis)

  • H1 receptor antagonism: Direct antagonist and negative agonist activity at Histamine-1 receptor
  • Mast cell stabilization: Inhibition of mast cell tryptase, preventing degranulation and release of pro-inflammatory mediators
  • COX-1 and COX-2 inhibition: Reduces prostaglandin formation
  • HPGDS inhibition: Inhibits Hematopoietic Prostaglandin D2 synthase, a central enzyme in allergic inflammation
  • Multi-target mechanism distinguishes nettle from single-target antihistamines

Diuretic Mechanism

  • Potassium-rich composition contributes to aquaretic (water-eliminating) effect
  • Flavonoids may enhance renal blood flow

Clinical Evidence Summary

Arthritis and Rheumatic Conditions

  • Commission E and ESCOP approval based on traditional evidence and controlled clinical studies
  • Controlled studies demonstrated adjuvant use in arthritis, arthrosis, and rheumatic conditions
  • Patient-reported outcomes: 80-95% of patients noted effectiveness; 93-95% reported good tolerability
  • Hox alpha extract: Specific standardized extract studied for anti-arthritic activity
    • In vitro: suppressed IL-1beta-induced MMP expression in human chondrocytes
    • Active compound: 13-HOTrE

Allergic Rhinitis

  • Mittman (1990): Randomized, double-blind study of freeze-dried Urtica dioica in allergic rhinitis

    • 98 enrolled, 69 completed
    • Freeze-dried nettle rated higher than placebo in global assessments
    • Diary data showed only slight superiority over placebo
    • 300 mg freeze-dried nettle, taken as needed
    • PMID: 2192379 — landmark study but small and methodologically limited
  • Bakhshaee et al. (2017): RCT of Urtica dioica root extract (150 mg Urtidin tablet) vs. placebo for allergic rhinitis

    • Note: this used ROOT extract, not leaf — different part
    • Showed benefit in symptom scores
  • In vitro evidence (Roschek et al., 2009) is strong:

    • Demonstrated multi-target anti-allergic mechanisms
    • H1 receptor antagonism, mast cell tryptase inhibition, COX-1/2 inhibition, HPGDS inhibition
    • Published in Phytotherapy Research
  • [NEEDS-RESEARCH] Large, well-designed RCTs of nettle leaf specifically for allergic rhinitis are still lacking

Diuretic/Urinary Tract

  • Traditional use well-documented
  • Limited modern clinical trial data
  • Used as part of irrigation therapy protocols in German phytotherapy

European vs. US/Anglophone Consensus

DimensionEuropean PositionUS/Anglophone Position
Regulatory statusCommission E and ESCOP approved for rheumatic complaints and urinary irrigationDietary supplement; no FDA approval
Arthritis useEstablished adjuvant therapy in German phytotherapyLess commonly recommended; some CAM practitioners use it
Allergy useNot in official monographs; used by naturopathic practitionersPopular in naturopathic medicine; freeze-dried nettle capsules widely available
Evidence perceptionModerate acceptance based on traditional evidence + controlled studiesGenerally considered under-researched
Root vs. leaf distinctionWell-understood in European phytotherapy (leaf = rheuma/allergy; root = BPH)Often confused in US consumer market

Safety Profile

Contraindications

  • Allergy to Urtica species (rare)
  • Edema due to impaired cardiac or renal function: Irrigation therapy contraindicated in these conditions (risk of fluid overload)

Drug Interactions

  • Diuretics: Potential additive diuretic effect (theoretical)
  • Anticoagulants: Nettle contains vitamin K; large amounts theoretically could reduce warfarin effectiveness (not clinically documented)
  • Antihypertensives: Potential additive hypotensive effect
  • Lithium: Diuretic effect could reduce lithium excretion, raising levels (theoretical)
  • Hypoglycemic agents: Some evidence for blood glucose effects; monitor

Side Effects

  • Very well tolerated
  • Occasional mild GI discomfort
  • Allergic skin reactions (rare, usually from fresh plant contact — stinging hairs contain histamine, formic acid, acetylcholine)
  • Dried/processed preparations do not cause stinging

Pregnancy/Lactation

  • Insufficient safety data — not recommended during pregnancy (EMA)
  • Traditional use as food (young nettle leaves as vegetable) is not considered concerning
  • Avoid concentrated extracts during pregnancy as a precaution

Clinical Dosage

Oral Preparations (Commission E / ESCOP)

  • Dried herb/leaf for tea (infusion): 8-12 g daily (some sources cite up to 12 g)
  • Pressed juice: 10-15 mL of fresh plant juice, 3 times daily
  • Dry extract: Various standardized extracts; dosing depends on extract ratio
  • Freeze-dried herb (Mittman protocol): 300 mg as needed for allergy symptoms

Hox alpha Extract

  • Standardized stinging nettle leaf extract
  • Used in rheumatic condition research
  • Active compound: 13-HOTrE
  • Specific dosing varies by product

Duration

  • For rheumatic complaints: can be used long-term as adjuvant therapy
  • For urinary irrigation: adequate fluid intake (at least 2 L/day) must accompany use
  • For allergic rhinitis: used during allergy season

Key Products (European Market)

  • Various nettle leaf tea preparations (Sidroga, etc.)
  • Hox alpha (Strathmann) — standardized antirheumatic extract
  • Bazoton (nettle leaf extract)
  • Urtidin (standardized extract)

Important Distinction: Leaf/Herb vs. Root

ParameterLeaf/Herb (this file)Root (urological module)
Drug nameUrticae folium/herbaUrticae radix
Primary indicationRheumatic complaints, urinary irrigation, allergic rhinitisBenign prostatic hyperplasia (BPH)
Key compoundsCaffeic acid esters, flavonoids, 13-HOTrELectins (UDA), sterols, lignans
MechanismAnti-inflammatory (NF-kB, COX, MMP)5-alpha-reductase inhibition, SHBG binding
Commission EApproved for rheuma, urinary irrigationApproved for BPH stages I-II

Sources

  • Commission E Monograph: Urticae herba/folium (Bundesanzeiger)
  • ESCOP Monograph: Urticae folium/herba (Nettle leaf/herb)
  • EMA/HMPC Assessment Report on Urtica dioica L., Urtica urens L., folium (Final)
  • Mittman (1990) “Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis” PMID: 2192379
  • Roschek et al. (2009) “Nettle extract affects key receptors and enzymes associated with allergic rhinitis” Phytotherapy Research
  • Schulze-Tanzil et al. (2002) “Effects of the antirheumatic remedy hox alpha on matrix metalloproteinases in human chondrocytes in vitro” PMID: 11962753
  • Altmeyers Encyclopedia: Urticae herba/folium and Urticae folium
  • Bakhshaee et al. (2017) “Efficacy of Supportive Therapy of Allergic Rhinitis by Stinging Nettle” PMC5963652

Connections

  • Nettle root (urological herbs module): Different part, different indication (BPH), different mechanism
  • Butterbur: Alternative herbal approach to allergic rhinitis
  • Turmeric Curcumin: Shares NF-kB inhibition mechanism for anti-inflammatory effects
  • Licorice: Both have anti-inflammatory properties via different pathways

Related Herbs

Butterbur

Petasites hybridus

C Moderate
High

Butterbur root extract (Petadolex) has some of the strongest clinical evidence of any herbal product for migraine prevention, with Class 1 RCTs showing 48-68% responder rates at 150 mg/day and a former AAN Level A recommendation. However, butterbur plants naturally contain hepatotoxic pyrrolizidine alkaloids (PAs). Although Petadolex is manufactured to be PA-free, reports of liver injury (whose causal relationship to butterbur is disputed) led to product withdrawal in Germany in 2009 and retirement of the AAN guideline. The herb represents a unique case where strong efficacy evidence collides with unresolved safety questions.

Read more →

Licorice

Glycyrrhiza glabra

C Moderate
High

Licorice root is one of the most important herbs in both European and Asian medicine, approved by Commission E and ESCOP for gastric/duodenal ulcers, gastritis, and respiratory catarrh. Its primary active compound glycyrrhizin (and its metabolite glycyrrhetinic acid) has potent anti-inflammatory and mucosal-protective effects but also causes mineralocorticoid-like adverse effects: sodium retention, potassium loss, and hypertension. This limits use to 4-6 weeks and a maximum glycyrrhizin intake of 100 mg/day. DGL (deglycyrrhizinated licorice) was developed to provide GI benefits without the hypertension risk and is effective for peptic ulcer symptoms when taken as chewable tablets.

Read more →

Turmeric / Curcumin

Curcuma longa

C Moderate
Moderate

Turmeric is approved in Europe as a traditional medicine for mild digestive complaints. Curcumin, its principal active compound, has potent anti-inflammatory and antioxidant activity in vitro but notoriously poor oral bioavailability. This has spawned a generation of enhanced formulations (Meriva, Longvida, Theracurmin) that dramatically improve absorption. Clinical evidence is most promising for osteoarthritis pain, with emerging data for IBD and metabolic syndrome. A rare but real hepatotoxicity signal has emerged, linked to the HLA-B*35:01 allele.

Read more →
esc
↑↓ navigate ↵ open esc close